Claritev (NYSE:CTEV), a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million (GAAP) in Q2 2025, which exceeded analyst estimates by $10.2 million (GAAP).
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with athenahealth, Inc. through the company's award-winning athenahealth® Marketplace program. Now available to athenahealth's growing network of ...
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV) today announced that the PHCS Network, the largest primary PPO in the nation, received its 12th consecutive Accreditation in Credentialing from the National Committee for Quality Assurance (NCQA), a private nonprofit organization dedicated to improving health care quality. The PHCS Network is the only ...
SAN FRANCISCO--(BUSINESS WIRE)--Fractional AI, a leading provider of bespoke generative AI solutions, today announced a new collaboration with Claritev, formerly known as MultiPlan. This collaboration aims to support Claritev's generative AI strategy by establishing a robust technical and strategic foundation for transformative AI initiatives across Claritev. “Claritev is approaching AI with bo...
MCLEAN, Va.--(BUSINESS WIRE)---- $CTEV #CTEV--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent, and fair for all, today announced it has joined the Coalition for Health AI (“CHAI”). CHAI is an industry-led coalition committed to developing industry best practices and fra...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.